Related Experiment Video
Updated: Oct 12, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
Federica Barutta1, Beatrice Corbetta2, Stefania Bellini2
1Diabetic Nephropathy Laboratory, Department of Medical Sciences, University of Turin, C/so Dogliotti 14, 10126, Turin, Italy. federica.barutta@unito.it.
Background:
MicroRNA-146a-5p (miR-146a-5p) is a key regulator of inflammatory processes. Expression of miR-146a-5p is altered in target organs of diabetic complications and deficiency of miR-146a-5p has been implicated in their pathogenesis. We investigated if serum miR-146a-5p levels were independently associated with micro/macrovascular complications of type 1 diabetes (DM1).
Methods:
A nested case-control study from the EURODIAB PCS of 447 DM1 patients was performed. Cases (n = 294) had one or more complications of diabetes, whereas controls (n = 153) did not have any complication. Total RNA was isolated from all subjects and miR-146a-5p levels measured by qPCR. Both the endogenous controls U6 snRNA and the spike (Cel-miR-39) were used to normalize the results. Logistic regression analysis was carried out to investigate the association of miR-146a-5p with diabetes complications.
Results:
MiR-146a-5p levels were significantly lower in cases [1.15 (0.32-3.34)] compared to controls [1.74 (0.44-6.74) P = 0.039]. Logistic regression analysis showed that levels of miR-146a-5p in the upper quartile were inversely associated with reduced odds ratio (OR) of all complications (OR 0.34 [95% CI 0.14-0.76]) and particularly with cardiovascular diseases (CVD) (OR 0.31 [95% CI 0.11-0.84]) and diabetic retinopathy (OR 0.40 [95% CI 0.16-0.99]), independently of age, sex, diabetes duration, A1c, hypertension, AER, eGFR, NT-proBNP, and TNF-α.
Conclusions:
In this large cohort of DM1 patients, we reported an inverse and independent association of miR-146a-5p with diabetes chronic complications and in particular with CVD and retinopathy, suggesting that miR-146a-5p may be a novel candidate biomarker of DM1 complications.
Insights
Lower serum levels of microRNA-146a-5p (miR-146a-5p) are linked to increased risk of type 1 diabetes complications. This suggests miR-146a-5p may serve as a novel biomarker for diabetic complications, particularly cardiovascular disease and retinopathy.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- MicroRNA-146a-5p (miR-146a-5p) is a crucial regulator of inflammation.
- Altered miR-146a-5p expression is observed in diabetic complication target organs, and its deficiency is implicated in pathogenesis.
- This study investigates the association between serum miR-146a-5p levels and micro/macrovascular complications in type 1 diabetes (DM1).
Purpose of the Study:
- To determine if serum miR-146a-5p levels are independently associated with micro/macrovascular complications in type 1 diabetes (DM1).
Main Methods:
- A nested case-control study involving 447 DM1 patients from the EURODIAB PCS was conducted.
- Serum miR-146a-5p levels were quantified using qPCR and normalized with U6 snRNA and Cel-miR-39 spike.
- Logistic regression analysis was employed to assess the association between miR-146a-5p levels and diabetes complications.
Main Results:
- Patients with diabetes complications (cases) exhibited significantly lower serum miR-146a-5p levels compared to controls.
- Higher miR-146a-5p levels (upper quartile) were inversely associated with a reduced odds ratio for all diabetes complications (OR 0.34).
- This inverse association was particularly noted for cardiovascular diseases (CVD) (OR 0.31) and diabetic retinopathy (OR 0.40), independent of other clinical factors.
Conclusions:
- Serum miR-146a-5p is inversely and independently associated with chronic complications of type 1 diabetes, including CVD and retinopathy.
- These findings suggest that miR-146a-5p may represent a novel candidate biomarker for predicting and monitoring diabetic complications.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

